Article
AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push
Pessimistic
-45.3
−100 Bearish
0
+100 Bullish
AbbVie said on Monday it would buy biotech Apogee Therapeutics for $10.9 billion, in more than five years.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Source
CNBC Top Stories
Published
Jun 22, 2026 · 11:49 am
Article ID
u57vsh0
Original URL
Open source
Sentiment Signal
Pessimistic
-45.3
−100Neutral+100
More Like This